Compare VIK & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIK | BDX |
|---|---|---|
| Founded | 1997 | 1897 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.6B | 43.0B |
| IPO Year | 2023 | 1997 |
| Metric | VIK | BDX |
|---|---|---|
| Price | $100.71 | $156.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $84.14 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.9M |
| Earning Date | 05-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $14.41 | N/A |
| Revenue Next Year | $14.16 | $3.02 |
| P/E Ratio | ★ $37.68 | $611.88 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $55.55 | $140.11 |
| 52 Week High | $105.76 | $213.08 |
| Indicator | VIK | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 57.46 | 55.88 |
| Support Level | $95.95 | $153.27 |
| Resistance Level | $105.76 | $160.40 |
| Average True Range (ATR) | 2.63 | 3.78 |
| MACD | -0.37 | -0.12 |
| Stochastic Oscillator | 70.06 | 54.76 |
Viking Holdings Ltd is a travel company, with a fleet of 92 small ships, which view as floating hotels. It offers travel experiences on all seven continents in all three categories of the cruise industry river, ocean, and expedition cruising. The Group defines its products based on the type of cruise offering and language of the cruise service. The River segment provides river cruises outside the United States to English-speaking passengers. The Ocean segment offers ocean cruises to English-speaking passengers. Other include operating segments that are not individually reportable, consisting of expedition cruises for English-speaking passengers (Expedition), Mississippi River cruises for English-speaking passengers, and Viking China, which includes cruises for Mandarin.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.